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SUMMARY
The colonization of the oral cavity is a prerequisite to the development of oropharyngeal candidiasis. Aims: The aims of this study 
were: to evaluate colonization and quantify Candida spp. in the oral cavity; to determine the predisposing factors for colonization; 
and to correlate the levels of CD4+ cells and viral load with the yeast count of colony forming units per milliliter (CFU/mL) in 
HIV-positive individuals treated at a University Hospital. Saliva samples were collected from 147 HIV patients and were plated on 
Sabouraud Dextrose Agar (SDA) and chromogenic agar, and incubated at 30 ºC for 72 h. Colonies with similar morphology in both 
media were counted and the result expressed in CFU/mL. Results: Of the 147 HIV patients, 89 had positive cultures for Candida 
spp., with a total of 111 isolates, of which C. albicans was the most frequent species (67.6%), and the mean of colonies counted was 
8.8 × 10³ CFU/mL. The main predisposing factors for oral colonization by Candida spp. were the use of antibiotics and oral prostheses. 
The use of reverse transcriptase inhibitors appears to have a greater protective effect for colonization. A low CD4+ T lymphocyte 
count is associated with a higher density of yeast in the saliva of HIV patients.
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INTRODUCTION
Acquired Immunodeficiency Syndrome (AIDS) is characterized by 
an impaired immune system, resulting in a continuing decrease in the 
number of CD4+ T lymphocytes. As a result of this, several opportunistic 
infections may be present in an individual infected with HIV, including 
cryptococcosis, histoplasmosis, pneumocystosis and candidiasis5,12,24.
Oropharyngeal candidiasis is the most common fungal infection 
in individuals with Human Immunodeficiency Virus (HIV), and 90% 
of them develop this infection at least once during the course of the 
disease3,21.
The introduction of highly active antiretroviral therapy (HAART) 
in the treatment of HIV infection causes a reduction in the occurrence 
of opportunistic infections. However, oropharyngeal candidiasis is still 
common among individuals with late diagnosis and those that do not 
respond successfully to treatment24,31. Currently, six classes of antiretroviral 
drugs are available in Brazil: nucleoside reverse transcriptase inhibitors, 
non-nucleoside reverse transcriptase inhibitors, protease inhibitors, 
integrase inhibitors, fusion inhibitors, and co-receptors4.
Colonization of the oral cavity does not always culminate in 
oropharyngeal candidiasis. However, such colonization can be considered 
a prerequisite for the development of the disease. Before the onset 
of symptoms of infection, there is usually an intense colonization by 
Candida spp.8,33. Other factors that favor the colonization of the oral 
cavity by Candida species include: smoking, diabetes mellitus, oral 
prostheses, extreme age, antibiotics, decreased salivary flow, food habits, 
and nutritional status10,24,29.
In oral fungal microbiota, and in other mucosal microbiota of the 
body, Candida species have been observed to be prevalent, with C. 
albicans being the species most often isolated. Meanwhile, in recent 
years, there has been an increase in isolation of other species including C. 
parapsilosis, C. tropicalis, C. glabrata, C. krusei and C. dubliniensis19,24,31.
An important marker for the carrier state or infection is the count 
of colony-forming units (CFUs) of yeast in the oral cavity. Individuals 
who are only carriers of Candida spp. have a colony count of < 1000 
CFU/mL of saliva, whereas individuals who have infection present with 
a colony count exceeding 4000 CFU/mL9,15.
The aims of this study were: to evaluate colonization and quantify 
Candida spp. in the oral cavity of HIV-positive individuals treated 
at a University Hospital; to determine the predisposing factors for 
colonization; and to investigate the correlation between the levels of 
CD4+ cells and viral load with the yeast count.
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PATIENTS AND METHODS
This study was classified as cross-sectional, which verified the 
presence of Candida spp. only at the time of saliva collection without 
monitoring the patient after sampling.
Research subjects and sample collection: saliva samples were 
collected from 147 seropositive HIV individuals in the Outpatient Clinic 
of Infectious Diseases of the Clinical Hospital of the Federal University 
of Uberlandia, Uberlandia, Minas Gerais State, Brazil.
During routine consultations in the Infectious Diseases Clinic, 
patients received guidelines about the study and were invited to participate 
in the research. This study was approved by the Ethical Committee for 
Human Research of the Federal University of Uberlandia, protocol 
368/11.
Demographic and clinical data for each individual research 
participant was obtained using a questionnaire, prior to collection of 
the saliva sample. Medical records were reviewed to obtain data such as 
age; form of HIV infection; time of diagnosis; use of antifungal agents 
and/or antibiotics within 30 days and/or seven days prior to collection 
of the saliva sample; antiretroviral therapy used; values of CD4+ cells; 
viral load (these values were measured up to two weeks prior to saliva 
collection); history of oral candidiasis; use of oral prostheses; and 
smoking status.
After that, patients were requested to collect approximately 2 mL of 
unstimulated saliva in sterilized tubs. When collecting the saliva sample, 
no patients had clinically active oral candidiasis.
Sample processing, quantification and identification of yeasts: 
the saliva sample was homogenized with sterile glass beads, and serial 
decimal dilutions were made (10-1 to 10-3) in sterile saline solution (0.9%). 
Then, aliquots of 10 µL of pure saliva and of the dilutions were added to 
plates containing Sabouraud Dextrose Agar (SDA) (Sigma, Rockville, 
USA) containing chloramphenicol (100 mg/L), and similarly to other 
plates containing Chromogenic Agar (Conda, Madrid, Spain). The plates 
were incubated at 30 °C for 72 h. Colonies with similar morphology in 
both media were counted and the result was expressed in colony-forming 
units per milliliter of saliva (CFU/mL).
Individual colonies from each sample were identified using the 
classical methodology and the Auxacolor2® system (Bio-Rad, Marnes-
la-Coquette, France), and thereafter stored in BHI-glycerol at −20 ºC, 
and in sterile distilled water kept at room temperature22,30.
The samples identified as C. albicans were submitted to molecular 
testing by polymerase chain reaction (PCR) for confirmation of the 
species or alternatively identification of C. dubliniensis. The DNA used 
in the PCR reactions was obtained according to the proposed by LUO & 
MITCHELL (2002) modified20. Three CFU previously grown in SDA for 
24 h were transferred to 50 µL of sterile distilled water and 2 µL of this 
cellular suspension were directly used in PCR. Specific primers were used 
for C. albicans (forward: 3’TTT ATC AAC TTG TCA CAC CAG A5’, 
reverse: 5’ATC CCG CCT TAC CAC TAC CG3’) and C. dubliniensis: 
(forward: 3’AAA TGG GTT TGG TGC CAA ATT A5’, reverse: 5’GTT 
GGC ATT GGC AAT AGC TCT A3’)13.
Statistical analysis: patients included in the study were divided 
into two groups based on the results of the saliva sample culture: (1) 
colonized and (2) non-colonized. All patients who yielded at least one 
colony of Candida spp. in the culture were included in the first group 
(Group 1). Group 2 included all individuals with negative culture for 
Candida species.
Qualitative variables associated with either Group 1 or 2 were 
investigated using p-values and the odds ratio (OR)-values. For analysis 
of differences in qualitative variables between the two groups of patients, 
the Mann-Whitney test was used. Comparison of the average CFU/mL 
with the range of CD4+ T lymphocytes and of viral load was performed 
using the Kruskal-Wallis test. Non-parametric tests were applied for the 
analysis of quantitative variables without normal probability distributions. 
All tests were applied using a significance level of 5%.
RESULTS
Of the 147 patients included in this study, 84 were male and 63 were 
female. Age ranged from 17-73, with a mean age of 44.7 and a median of 
44. Of the 147 patients, 101 (68.7%) acquired HIV by heterosexual contact, 
19 (12.9%) by homosexual contact, one (0.7 b%) congenitally, one (0.7%) 
by a work-related accident, one (0.7%) through a blood transfusion, and 
24 patients (16.3%) were unable to inform how they were infected. The 
mean time for diagnosis of HIV infection was 8.4 years. Within this study 
group, 13 patients (8.8%) did not use any antiretroviral therapy at the time of 
collection of saliva sample; 68 (46.3%) used reverse transcriptase inhibitors, 
61 (41.5%) used a protease inhibitor associated with a transcriptase 
inhibitor, and five (3.4%) combined the use of protease inhibitors with 
antiretroviral transcriptase and integrase inhibitors.
Candida spp. was isolated in 60.5% (89) of the patients, with a total 
of 111 isolates, and C. albicans was the most frequent species (67.6%). 
Candida non-Candida species accounted for 32.4% of the total isolates 
(Table 1). Among the 89 patients with a positive Candida species culture, 
69 (77.5%) were colonized by only one species of Candida, and 20 
(22.5%) had a combination of two or more species (Table 1).
The mean count of colonies per milliliter of saliva was 8.8 × 10³ 
CFU/mL, and the median was 8 × 10² CFU/mL (ranging from 10² to 5 
× 105 CFU/mL).
Fig. 1 - Agarose gel electrophoresis of specific primer for Candida albicans (Aa) and Candida 
dubliniensis (Bb). Aa: A) Molecular weight, B) C. albicans ATCC90028, 1-11) study samples. 
Bb: A) molecular weight, B) C. albicans ATCC90028, C) C. dubliniensis INCQS 40172, D) 
negative control, 1-2) study samples.
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Predisposing factors for colonization of the oral cavity by Candida 
species are listed in Table 2. There was a significant statistical difference 
between colonized and non-colonized individuals with respect to the use 
of antibiotics (p = 0.0254, OR = 3.2) and the use of dental prostheses 
(p = 0.0173, OR = 2.46). However, use of HAART (p = 0.5671), use 
of antifungal agents (p = 0.7102), smoking (p = 0.3868), gender (p = 
0.4215), age (p = 0.2529), CD4+ cell count (p = 0.5234), viral load (p = 
0.2954), history of candidiasis (p = 0.8628), and time of HIV diagnosis 
(p = 0.2758) did not differ significantly between colonized and non-
colonized patients.
By analyzing the relationship between HAART (which includes 
different classes of antiretroviral drugs) and oral colonization by Candida 
spp., it was found that individuals who used a combination of reverse 
transcriptase inhibitors and protease inhibitors were more likely to be 
colonized than those using reverse transcriptase inhibitors alone (p = 
0.0315). When comparing other therapeutic regimens among themselves 
and with those individuals who were not receiving HAART at the time of 
collection, no statistical differences were observed (p > 0.05). Compared 
with the other therapeutic schemes, and those who did not use HAART, 
no statistical difference was observed (p > 0.05).
The mean count of CD4+ cells was 551 cells/mm³, and the median 
was 557 cells/mm³ (range, 3–1619 cells/mm³). There were 25 (17%) 
patients who had < 200 CD4+ cells/mm³ at the time of collection of the 
saliva; 108 (73.4%) patients had an undetectable viral load (< 50 copies/
mL), whereas 13 (8.8%) had a viral load of > 20,000 copies/mL.
Comparing the CD4+ cell count and the viral load of patients who 
had at least one isolate of Candida spp. in the oral cavity with those who 
had a negative culture, a very close p-value of 0.05 yielded in the range 
of 0–200 cells/mm³ in the case of CD4+ (p = 0.0546) (Table 3). The viral 
load did not differ significantly between colonized and non-colonized 
individuals (Table 3).
Comparing the mean of the CFU/mL in saliva for the different ranges 
of CD4+ T lymphocytes, it was observed that those within the range of 
0–200 CD4+ cells/mm³ tended to have a greater CFU/mL than those 
patients with CD4+ cells > 350 cells/mm³ (p = 0.0001) (Table 4). This 
statistical difference was not observed when comparing the mean CFU/
mL between the different ranges of viral load (Table 4).
DISCUSSION
Persistent colonization of the oral cavity by Candida spp. can be 
considered a predisposing factor for the development of oropharyngeal 
candidiasis11,16. In HIV patients, this has been given considerable 
attention due to the high incidence of oropharyngeal candidiasis and a 
high density of yeast in the oral cavity may be an important marker for 
disease progression1,3.
The frequency of HIV-positive individuals colonized by Candida 
spp. (as well as the species present) varies between different regions of 
the planet as a result of geographical, climatic and ethnic differences6,23. 
In this study, 60.5% of saliva samples were positive for Candida species. 
Studies show that in Brazil the rate of colonization has ranged from 58 
to 62% in patients with HIV6,21. However, in countries such as Mexico, 
Turkey, Argentina and USA, higher rates have been reported11,24,27,28.
The predominant species found in this study was C. albicans (67.6%), 
corroborating the findings of similar studies in Sao Paulo, Argentina and 
Nigeria, which yielded a frequency of C. albicans of 51.5%, 58.9% and 
45%, respectively21,24,26. Candida non-albicans species accounted for 
32.4% of the total isolates: C. parapsilosis, (followed by C. tropicalis), 
was the most common. This frequency is higher than that reported by 
LI et al. in China23 (19.8%) and by WINGETER et al. in southern Brazil 
(7%)34. However, this increased percentage of Candida non-albicans 
species, besides having a major effect on clinical procedures, confirms 
a trend observed in other similar studies11,25.
Table 1 
Distribution and frequency of association of Candida species isolated from the oral cavity of HIV patients treated at the Outpatient Clinic of Infectious Diseases of 
the Clinical Hospital of the Federal University of Uberlandia, Minas Gerais, Brazil, in t2012
Species Frequency of isolates
Percentage 
(%) Association of different species
Frequency of 
isolates Percentage (%)
C. albicans 75 67.6 C. albicans + C. parapsilosis 6 30
C. parapsilosis 10 9.0 C. albicans + C. tropicalis 5 25
C. tropicalis 8 7.2 C. albicans + C. glabrata 2 10
C. glabrata 5 4.5 C. albicans + C. krusei 2 10
C. krusei 4 3.6 C. albicans + C. kefyr 1 5
C. dubliniensis 3 2.7 C. dubliniensis + C. lusitaniae 1 5
C. kefyr 2 1.8 C. albicans + C. dubliniensis 1 5
C. famata 1 0.9 C. albicans + C. parapsilosis + C. tropicalis 1 5
C. guilliermondii 1 0.9 C. albicans + C. glabrata + C. tropicalis 1 5
C. lusitaniae 1 0.9
C. peliculosa 1 0.9
111 100 20 100
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Colonization by more than one Candida species has been reported 
previously11,23,24. In our study, 22.5% of patients were colonized by at 
least two species, and association was predominantly between C. albicans 
and C. parapsilosis (six of 20). Other studies have showed predominant 
association between C. albicans and C. glabrata11,21,23,24.
Analysis of the concentration of yeast in saliva (8.8 × 103 CFU/mL) 
was higher than that previously observed in Sao Paulo (Brazil) and in the 
south of India (5.2 × 10² CFU/mL and 3 × 10² CFU/mL, respectively). 
However, the technique used for collecting that material was a swab 
of the oral cavity and rinse in sterile phosphate-buffered saline, 
respectively17,21. There is no consensus on the cut-off level of CFU/mL 
differentiating individuals colonized by yeast or having oropharyngeal 
candidiasis, yeast count > 4 × 10³ CFU/mL can be considered a sign of 
Table 2 
Clinical characteristics and rate of Candida oral colonization in 147 patients with HIV treated at the Outpatient Clinic of Infectious Diseases of the Clinical Hospital 
of the Federal University of Uberlandia, Minas Gerais, Brazil, in 2012
Factors predisposing Colonized (89) Non-colonized (58) p-value OR
Use of antibiotics 24 (27%) 6 (10.3%) 0.0254 3.2000
Use of antifungal 5 (5.6%) 5 (8.6%) 0.7102 0.6310
Smoker 0.3868
Yes 27 (30.3%) 13 (22.4%) 1.5074
No 62 (69.7%) 45 (77.6%) 0.6634
Use of dental prostheses 0.0173
Yes 45 (50.6%) 17 (29.3%) 2.4666
No 44 (49.4%) 41 (70.7%) 0.4054
Use of HAART 80 (89.9%) 54 (93.1%) 0.5671 1.5146
Sex 0.4215
Female 41 (46%) 22 (37.9%) 1.3977
Male 48 (54%) 36 (62.1%) 0.7154
Age 45.6 43.5 0.2529
CD4+ 544 ± 331 562 ± 319 0.5234
Viral load 20215.7 ± 88698 5387.2 ± 21473.9 0.2954
Historical of oral candidiasis  
Yes 27 (30.4%) 16 (27.6%) 0.8628 1.1431
No 62 (69.6%) 42 (72.4%) 0.8748
Table 3 
Frequency of HIV-positive individuals colonized and not colonized by Candida spp. according to the CD4+ T lymphocyte cell count and viral load of patients treated 
at the Outpatient Clinic of Infectious Diseases of the Clinical Hospital of the Federal University of Uberlandia, Minas Gerais, Brazil, in 2012
CD4 (cells/mm³) Colonized (89) Not colonized (58) p-value
No. of individuals Average (CD4) No. of individuals Average (CD4)
0-200 17 (19.1%) 123.7 8 (13.8%) 70.3 0.0546
201-350 9 (10.1%) 273.2 11 (19%) 271.3 1.0000
>350 63 (70.8%) 694.6 39 (67.2%) 743.5 0.1164
Total 89 (100%) 544.1 58 (100%) 561.1 0.5234
Viral load (CFU/mL) No. of individuals Average (viral load) No. of individuals Average (viral load)
<50 62 (69.6%) – 46 (79.3%) – 1.0000
51-20000 18 (20.2%) 4317.8 8 (13.8%) 6047.5 0.4899
>20000 9 (10.2%) 191274.8 4 (6.9%) 66021.7 0.1474
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oral candidiasis9,15. The discrepancy in the average CFU/mL between 
studies may be explained by the different methodology used for 
collection of the saliva sample, as some techniques are more sensitive 
than others11.
Ways of reducing colonization may contribute to a decreased incidence 
and severity of oral candidiasis or even to a decreased risk of candidemia, 
hence the importance of identifying the individual’s characteristics and 
habits that are associated with high oral cavity colonization by Candida 
spp., together with any potential modifications to these characteristics 
and habits. The use of antibiotics and dental prostheses were considered 
predisposing factors for colonization of the oral cavity by Candida species 
(and probably for the development of oral candidiasis). A similar study in 
Taiwan also observed the relationship between these two factors and oral 
colonization by Candida spp35. This relationship is explained by the fact 
that prolonged administration of antibiotics can cause an imbalance in the 
oral microbiota, thus allowing the proliferation of other microorganisms 
present there, including Candida species7. However, the use of an oral 
prosthesis is an important factor in colonization because of the trauma 
that the mucosa may suffer if it is not adjusted correctly, and/or due to 
poor hygiene, that also may occur14.
In the present study, the frequency of individuals colonized or not by 
Candida spp. was not related to the use of HAART therapy, confirming 
the results obtained in similar studies11,18,27. However, ARRIBAS et 
al.2, LI et al.23 and YANG et al.36 observed a significant reduction in 
the rate of oral colonization in individuals who were using HAART. 
When we analyzed the relationship of a range of therapeutic regimens 
involving a number of classes of antiretroviral drugs, it was observed 
that the schema that included reverse transcriptase inhibitors combined 
with protease inhibitors was related to a greater frequency of colonized 
individuals compared with individuals whose HAART therapy included 
only a combination of reverse transcriptase inhibitors. YANG et 
al.36, observed a significant reduction in the rate of oral colonization, 
among those individuals included in their studies, that was related 
to the use of HAART therapy without, however, relating the class of 
drugs used. 
A reduced frequency of individuals with HIV colonized by Candida 
spp. has also been reported by WU et al.35, who demonstrated a reduction 
of oral colonization by Candida yeasts among individuals who used 
transcriptase inhibitors only. Possible mechanisms for the influence of 
HAART on oral colonization by Candida spp. are unknown. However, 
an explanation for the relationship between the use of protease inhibitors 
and an increased incidence of oral colonization by Candida species may 
be the greater immunological impairment and longer HIV infection 
period of individuals using protease inhibitors at the time of saliva 
sample collection, since the use of this class of antiretrovirals is only 
recommended when the combination of other classes of antiretrovirals 
has been ineffective in combating viral replication and, consequently, 
controlling HIV infection. Nevertheless, other studies may seek to 
confirm these findings, and thus contribute to elucidating the possible 
mechanisms that interfere with the proliferation of microorganisms and 
their adherence to the surface of the oral cavity.
Previous studies have sought to investigate the relationship between 
oral cavity colonization by Candida species with counts of CD4+ cells 
and viral load21,24,27. 
When comparing the load of yeast present in the saliva of individuals 
colonized by Candida spp. with CD4+ T lymphocyte count and viral load, 
it was observed that patients with a lower count of CD4+ cells showed a 
higher CFU/mL of saliva. This suggests that a low CD4+ cell count may 
be associated with a higher number of yeast in the saliva of individuals 
with HIV. This relationship may be explained by the hypothesis that HIV 
infection may not only compromise the oral mucosal immunity but also 
stimulate the expression of virulence factors in the yeasts, since it has 
been observed, in vitro, that HIV stimulates the secretion of a proteolitic 
enzyme by C. albicans32. However, when the same comparison was made 
in relation to the viral load of the subjects studied, this was not found to 
have a statistically significant difference, maybe because the number of 
subjects studied was insufficient to demonstrate the relationship. To the 
best of our knowledge, there are no studies in the literature that have set 
out to examine the relationship of the concentration of yeasts in saliva 
to the CD4+ cell count and the viral load.
In conclusion, it was observed that despite C. albicans being the 
most frequent species, the Candida non-albicans species represented a 
significant percentage of isolates. In addition, the yeast count in the saliva 
of patients was greater than that observed in previous studies. The use of 
antibiotics and oral prostheses are directly related to oral colonization by 
Candida spp. However, the use of HAART had no statistically significant 
influence in reducing the colonization of the site in question, but use of 
the antiretroviral class of reverse transcriptase inhibitors alone appears to 
have a greater protective effect against colonization. Finally, a low CD4+ 
T lymphocyte count seemed to be associated with a higher number of 
yeast being present in the saliva of HIV patients.
Table 4 
Relationship between number of CD4+ cells and concentration of yeasts (CFU/
mL) and viral load and concentration of yeasts in the saliva of HIV-positive 
patients treated at the Outpatient Clinic of Infectious Diseases of the Clinical 
Hospital of the Federal University of Uberlandia, in 2012
CD4+ 
(cells/mm³)
Colonized CFU/mL 
(average)
p-value
0-200a 17 7.4 × 10³ ab0.2631
201-350b 9 5.5 × 10³ ac0.0001
>350c 63 9.7 × 10³ bc0.0948
Viral load 
(copies/mL)
<50d 62 9.8 × 10³ de0.2259
51-20000e 18 3.6 × 10³ df:0.4549
>20000f 9 8.0 × 10³ ef0.1270
Total 89 8.8 × 10³
Note: a, b, c: variation ranges of CD4 cells used as a reference at the Outpatient 
Clinic of Infectious Diseases of the Clinical Hospital of the Federal University of 
Uberlândia, to begin, maintain or change antiretroviral therapy until the conclu-
sion of this study ab, ac, bc: results from the statistical comparison between the 
mean of CFU/mL of three tracks CD4+ T lymphocytes. d, e, f: variation ranges 
of viral load. ab, ac, bc: result of statistical comparison between the mean CFU/
mL of three tracks viral load.
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RESUMO
Fatores relacionados a colonização da cavidade bucal de 
indivíduos portadores do HIV por espécies de Candida
A colonização da cavidade oral pode ser considerada um pré-
requisito para o desenvolvimento de candidíase orofaríngea. Os objetivos 
deste estudo foram: avaliar e quantificar espécies de Candida isoladas 
da cavidade oral, para determinar os fatores predisponentes para a 
colonização, e correlacionar os níveis de células CD4+ e carga viral 
em indivíduos HIV-positivos atendidos em um hospital universitário. 
Foram coletadas amostras de saliva de 147 pacientes portadores do 
HIV, as quais foram semeadas em Ágar Sabouraud Dextrose (ASD) e 
ágar cromogênico e incubadas a 30 °C por 72 horas. As colônias com 
morfologia semelhante em ambos os meios foram contadas e o resultado 
expresso em unidade formadora de colônias por mililitro (UFC/mL). 
Dos 147 pacientes HIV positivos, 89 apresentaram culturas positivas 
para Candida spp., totalizando 111 isolados, e C. albicans foi a espécie 
mais frequente (67,6%). A contagem média de colônias foi de 8.8 × 10³ 
UFC/mL. Os principais fatores predisponentes para colonização oral 
por Candida spp. foram a utilização de antibióticos e de próteses orais. 
O uso de antirretroviral da classe de inibidores da transcriptase reversa 
pareceu ter maior efeito protetor para a colonização. Baixa contagem de 
linfócitos T CD4+ está relacionada com maior densidade de leveduras 
na saliva de indivíduos HIV positivos.
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